Dolutegravir 5 mg como tratamento complementar ou substitutivo em crianças com HIV de 2 meses a 6 anos de idade / Dolutegravir 5 mg as complementary treatment or substitute in children with HIV aged 2 months to 6 years
Brasília; CONITEC; jun. 2023.
Non-conventional
in Portuguese
| BRISA/RedTESA
| ID: biblio-1509370
Responsible library:
BR1.1
Subject(s)
Full text:
Available
Collection:
Tematic databases
Database:
BRISA/RedTESA
Main subject:
HIV Infections
/
Integrase Inhibitors
Type of study:
Evaluation study
/
Health technology assessment
Limits:
Child
/
Child, preschool
/
Humans
/
Infant
Country/Region as subject:
South America
/
Brazil
Language:
Portuguese
Year:
2023
Document type:
Non-conventional
